ARBS — Arterra Bioscience SpA Share News
0.000.00%
Last trade - 00:00- €18.11m
- €17.03m
- €4.65m
Brief: Arterra Bioscience Q1 Revenue Up To EUR 1.1 Mln
Brief: Arterra Bioscience FY Net Profit Down To EUR 1.1 Mln
Brief: Arterra Bioscience Prelim. FY Revenue Down To EUR 3.3 Mln
Brief: Arterra Bioscience, 9-Month Prelim Revenue Down To EUR 2.6 Mln
Brief: Arterra Bioscience To Start Buyback Program For Up To 20% Of Share Capital
Brief: Arterra Bioscience H1 Net Profit Down To EUR 0.2 Mln
Brief: Arterra Bioscience Prelim. H1 Revenue Down To EUR 1.6 Mln
Brief: Arterra Bioscience FY Net Profit Up To EUR 1.4 Mln
Brief: Arterra Bioscience, ABResearch Signs Medical Partnership
Brief: Arterra Bioscience Shareholder Zeus Capital Crosses 5% Threshold
Brief: Arterra Bioscience 9-Month Prelim. Revenue Up To EUR 2.9 Mln
Brief: Arterra Bioscience H1 Net Profit Up To EUR 0.7 Mln
Brief: Arterra Bioscience H1 Prelim. Revenue Up To EUR 2.1 Mln
Brief: Arterra Bioscience Q1 Total Revenue Up To EUR 1.0 Mln
Brief: Arterra Bioscience Selling Shareholders Complete Sale Of 23.3% Of Capital Share Via ABB For About EUR 2.8 Mln
Brief: Isagro, Maaerten Chrispeels Start Sale Of Up To 1,552,655 Arterra Bioscience Ordinary Shares Via ABB
Brief: Arterra Bioscience FY Net Profit Stable At EUR 1.1 Mln
Brief: Arterra Bioscience H1 Net Profit Up At EUR 390,602
Brief: Arterra Bioscience Files Patent Application For Prevention, Treatment Of Atopic Dermatitis